TickerFactsScreenerDevelopers

HERON THERAPEUTICS, INC. /DE/ (HRTX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2009: $6.80M2010: $1.32M2011: $15.75M2012: $51.82M2013: $68.94M2014: $63.06M2015: $118.11M2016: -$21.25M2017: $131.14M2018: $370.16M2019: $403.83M2020: $236.49M2021: $77.57M2022: $13.57M2023: -$33.97M2024: -$33.65M2025: $14.33M$14.33M
2009Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$14.33M+142.6%
2024-$33.65M+0.9%
2023-$33.97M-350.3%
2022$13.57M-82.5%
2021$77.57M-67.2%
2020$236.49M-41.4%
2019$403.83M+9.1%
2018$370.16M+182.3%
2017$131.14M+717.1%
2016-$21.25M-118.0%
2015$118.11M+87.3%
2014$63.06M-8.5%
2013$68.94M+33.1%
2012$51.82M+229.0%
2011$15.75M+1097.0%
2010$1.32M-80.6%
2009$6.80M—